
TSE:CGY
This summary was created by AI, based on 1 opinions in the last 12 months.
Calian Group Ltd (CGY-T) has received positive feedback from experts, highlighting that it is a well-managed company. Recent performance metrics indicate that the company recently hit a 52-week high, showcasing impressive momentum in the market. The current quarter's results were deemed satisfactory, further bolstering confidence among analysts. Experts recommend continuing to hold the stock, implying a stable outlook and potential for future growth. Overall, the sentiments around Calian Group Ltd suggest a strong position in its sector, backed by solid operational performance.
He used to own it a long time ago. It stalled out and he sold. It is finally getting traction again. They are trying to diversify the business. If they lose a big contract it could really impact the results. The dividend is safe. He would like to buy it much more cheaply but he would not buy at these levels.
It does 145 pharmacies by Loblaw’s (L-T) and medical services for the Canadian Defence Department, as well as a satellite business out of Saskatoon. One of the most consistently profitable small-cap companies for the last 5 years. 4% dividend yield. (Analysts’ price target is $31.00.)